Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 9:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 1,992 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 1 Clear all

Conditions: TSC
Interventions: JASPER; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 12 Months to 36 Months
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hemophilia B, Hemophilia A
Interventions: Standard of Care FIX Replacement therapy, Standard of Care FVIII Replacement therapy; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 13
States / cities: Palo Alto, California • San Francisco, California • Stanford, California + 7 more

Conditions: Carcinoma, Renal Cell
Interventions: Stereotactic Body Radiation Therapy (SBRT), Microwave Ablation (MWA); Radiation · Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Spinal Cord Injury
Interventions: Multi-Family Group Treatment, SCI Education Control Group; Behavioral
Lead sponsor: St. Luke's Rehabilitation Institute; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Cancer
Interventions: JTX-8064, pimivalimab; Drug
Lead sponsor: Jounce Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 45
States / cities: Birmingham, Alabama • Gilbert, Arizona • Tucson, Arizona + 37 more

Conditions: Cancer, Pulmonary Embolism
Interventions: CT pulmonary angiogram and d-dimer draw; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Literacy
Interventions: Functional Literacy Program, Usual Care Management Services; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer Female, Ovarian Cancer, Gastric Cancer
Interventions: Nivolumab, Ipilimumab; Biological
Lead sponsor: ExcellaBio LLC; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Cardiovascular Diseases
Interventions: Psychosocial Intervention, Structural Intervention, Traditional Psychosocial+Structural, Integrated Psychosocial+Structural; Behavioral · Other
Lead sponsor: University of Southern Mississippi; Other
Eligibility: 25 Years to 50 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Hattiesburg, Mississippi

Conditions: Achondroplasia
Interventions: BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe; Combination Product · Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Metastatic Urothelial Cancer
Interventions: AGS15E; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 8
States / cities: Birmingham, Alabama • New Haven, Connecticut • Detroit, Michigan + 5 more

Conditions: Social Isolation
Interventions: CONNECTED, VET BEFRIENDING; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Knee Pain Chronic, Knee Swelling Pain, Arterial Occlusion
Interventions: Embozene Microspheres; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 40 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pain, Acute, Motor Activity
Interventions: pain delivery - learning only, pain delivery - learning and retention; Procedure
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 35 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Renal Failure, Obesity
Interventions: Inamed Lap-Band System; Device
Lead sponsor: Summa Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Akron, Ohio

Conditions: Alcohol Misuse
Interventions: Mobile Health Intervention to Reduce Alcohol Use Among Young Adults; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 25 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Post Traumatic Stress Disorder
Interventions: Aim 2: BounceBack Now (BBN) for Trauma Informed Care Deployment, Aim 1 Participant Focus Groups, Aim 1 BHP Focus Groups, Aim 2: BHP, Provider, Staff and Admin Focus Groups, Aim 2 : Participant Focus Group; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Omaha, Nebraska

Conditions: Alcohol Use Disorder
Interventions: CI-581a, CI-581b, MBRP, MET; Drug · Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 21 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Sclerosis
Interventions: The Kessler Foundation modified Story Memory Technique® (KF-mSMT®), Aerobic Exercise Training (AET) plus Virtual Reality (IDEAL), Stretching and Toning (S/T); Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 70 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Social Anxiety Disorder
Interventions: Pico Goblin VR headset; Device
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Bladder Function
Interventions: cystometry, polysomnography; Procedure
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 45 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: PreDiabetes
Interventions: NDPP-Flex, NDPP; Behavioral
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Scabies
Interventions: Permethrin Cream, 5%, Elimite; Drug
Lead sponsor: Mayne Pharma International Pty Ltd; Industry
Eligibility: 12 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Miami, Florida • Richland, Washington

Conditions: Preoperative Aerobic Training, Solid Tumors
Interventions: treadmill walking (Proof-of-Concept), treadmill walking Dose-Finding / Escalation; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 19 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 8
States / cities: Los Angeles, California • Basking Ridge, New Jersey • Middletown, New Jersey + 5 more

Search by objective public record fields.

TSC Remote Assessment and Intervention

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma

Comparison of Two Psycho-educational Family Group Interventions for Persons With SCI and Their Caregivers

Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors

Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population

Effectiveness of a Functional Literacy Program for Formerly Homeless Adults

Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients

Nutrition360: Moving to Integrated and Holistic Disease Prevention Among Underserved Mississippians

Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants

ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer

Increasing Veterans' Social Engagement and Connectedness

Genicular Artery Embolization (GAE) for the Treatment of Chronic Post Knee Arthroplasty Pain

Effects of Acute Pain vs Context Change on Motor Learning Retention in Young Adults

Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients

Mobile Alcohol Use Intervention

Using Mobile Technology to Address the Trauma Mental Health Treatment Gap

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia

Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects

Patient-centered Goal Setting in the National Diabetes Prevention Program

Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.

Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors